Brind.

MIaMI presented AD biomarker data from the BROADWAY trial during a conference call in the Netherlands.

1 report, 1 independent Updated Jul 22

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

MIaMI Netherlands

Keep exploring

The entities involved

MIaMI
Czech company
- Ken Griffin, founder of Citadel, is expanding his real estate empire from Manhattan to Miami, driven by tax considerations.Thu 21:27
- High-level talks are underway to extend a trade truce, with the discussions taking place in locations including Miami, Busan, and New York.Thu 01:21
Netherlands
one of the four autonomous countries of the Kingdom of the Netherlands; with territories in the Caribbean
- The Kingdom of the Netherlands, comprising entities like Aruba, Curaçao, and Sint Maarten, is detailed, including the co-hosting of a climate conference in Colombia.Mon 16:13
- Aruba, Curaçao, Sint Maarten, and the Netherlands collaborated on digitizing historical meteorological archives.Mon 16:13

Coverage

Newest first; wire copies grouped

Jul 22GlobeNewswireNewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025 – NewAmsterdam to host conference call at 10:00 a.m. ET on Wednesday, July 30th – NAARDEN, the Netherlands a